The HLA-DQ(alpha 1*0102,beta 1*0602) heterodimer may confer susceptibility to multiple sclerosis in the absence of the HLA-DR(alpha 1*01,beta 1*1501) heterodimer

被引:41
作者
Spurkland, A
Celius, EG
Knutsen, I
Beiske, A
Thorsby, E
Vartdal, F
机构
[1] ULLEVAL HOSP,DEPT NEUROL,OSLO,NORWAY
[2] CENT HOSP AKERSHUS,DEPT NEUROL,LORENSKOG,NORWAY
来源
TISSUE ANTIGENS | 1997年 / 50卷 / 01期
关键词
HLA-DQ; multiple sclerosis; HLA-DR;
D O I
10.1111/j.1399-0039.1997.tb02828.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The frequencies of DR2, DQ6-related DRB1, DQA1, DQB1 haplotypes were compared in 181 multiple sclerosis patients and 294 controls in Norway. All individuals carried either DR2 or DQ6, i.e., the DQ(alpha 1*0102, beta 1*0602) heterodimer. The DR(alpha 1*01,beta 1*1501) and the DQ(alpha 1*0102, beta 1*0602) heterodimers were carried by 171 of the patients (94%) and 289 (98%) of the controls. Seven of the patients and one of the controls carried the DQ(alpha 1*0102,beta 1*0603) heterodimer together with the DR(alpha 1*01, beta 1*1501) heterodimer. Two patients carried the DQ(alpha 1*0102,beta 1*0602) heterodimer in the absence of the DR(alpha 1*01,beta 1*1501) heterodimer. The DR(alpha 1*01,beta 1*1501) heterodimer was not observed in the absence of the DQ(alpha 1*0102,beta 1*0602) heterodimer or the DQ(alpha 1*0102,beta 1*0603) heterodimer, neither in the patients nor in the controls. Our findings indicate that the genes encoding the DQ(alpha 1*0102,beta 1*0602) heterodimer may confer susceptibility to developing multiple sclerosis in the absence of the DRB1*1501 allele.
引用
收藏
页码:15 / 22
页数:8
相关论文
共 40 条
[1]   ASSOCIATION OF SUSCEPTIBILITY TO MULTIPLE-SCLEROSIS IN SWEDEN WITH HLA CLASS-II DRB1 AND DQB1 ALLELES [J].
ALLEN, M ;
SANDBERGWOLLHEIM, M ;
SJOGREN, K ;
ERLICH, HA ;
PETTERSON, U ;
GYLLENSTEN, U .
HUMAN IMMUNOLOGY, 1994, 39 (01) :41-48
[2]   EVOLUTIONARY RELATIONSHIPS OF HLA-DR8 ALLELES AND DESCRIPTION OF A NEW SUBTYPE (DRB1-ASTERISK-0806) IN THE ALGERIAN POPULATION [J].
BENMAMAR, D ;
MARTINEZLASO, J ;
VARELA, P ;
BEKHOUCHA, F ;
MORALES, P ;
ARNAIZVILLENA, A .
HUMAN IMMUNOLOGY, 1993, 36 (03) :172-178
[3]   NOMENCLATURE FOR FACTORS OF THE HLA SYSTEM, 1994 [J].
BODMER, JG ;
MARSH, SGE ;
ALBERT, ED ;
BODMER, WF ;
DUPONT, B ;
ERLICH, HA ;
MACH, B ;
MAYR, WR ;
PARHAM, P ;
SASAZUKI, T ;
SCHREUDER, GMT ;
STROMINGER, JL ;
SVEJGAARD, A ;
TERASAKI, PI .
HUMAN IMMUNOLOGY, 1994, 41 (01) :1-20
[4]  
BUGAWAN TL, 1994, AM J HUM GENET, V54, P331
[5]  
FERNANDEZVINA MA, 1992, HLA 1991, V1, P471
[6]   MULTIPLE-SCLEROSIS IN NORTHEAST SCOTLAND - AN ASSOCIATION WITH HLA-DQW1 [J].
FRANCIS, DA ;
BATCHELOR, JR ;
MCDONALD, WI ;
HING, SN ;
DODI, IA ;
FIELDER, AHL ;
HERN, JEC ;
DOWNIE, AW .
BRAIN, 1987, 110 :181-196
[7]  
GIPHART MJ, 1992, HLA 1991, P457
[8]   ALLELIC SEQUENCE VARIATION OF THE HLA-DQ LOCI - RELATIONSHIP TO SEROLOGY AND TO INSULIN-DEPENDENT DIABETES SUSCEPTIBILITY [J].
HORN, GT ;
BUGAWAN, TL ;
LONG, CM ;
ERLICH, HA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (16) :6012-6016
[9]  
JERSILD C, 1972, LANCET, V1, P1240
[10]  
JERSILD C, 1973, LANCET, V2, P1221